中国乳腺癌筛查与早期诊断指南

中国抗癌协会乳腺癌专业委员会单位

doi:10.19401/j.cnki.1007-3639.2022.04.010

您当前的位置：

首页 >

文章列表页 >

中国乳腺癌筛查与早期诊断指南

指南与共识 | 更新时间：2025-12-31

- 中国乳腺癌筛查与早期诊断指南
- Screening and early diagnosis of breast cancer in China: a practice guideline
- 中国癌症杂志 2022年32卷第4期页码：363-372
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.04.010
  中图分类号： R737.9
- 纸质出版：2022-04-30
- 稿件说明：
移动端阅览
中国抗癌协会乳腺癌专业委员会单位. 中国乳腺癌筛查与早期诊断指南[J]. 中国癌症杂志, 2022,32(4):363-372.

Society of Breast Cancer The, Anti-Cancer Association China. Screening and early diagnosis of breast cancer in China: a practice guideline[J]. China Oncology, 2022, 32(4): 363-372.
中国抗癌协会乳腺癌专业委员会单位. 中国乳腺癌筛查与早期诊断指南[J]. 中国癌症杂志, 2022,32(4):363-372. DOI： 10.19401/j.cnki.1007-3639.2022.04.010.

Society of Breast Cancer The, Anti-Cancer Association China. Screening and early diagnosis of breast cancer in China: a practice guideline[J]. China Oncology, 2022, 32(4): 363-372. DOI： 10.19401/j.cnki.1007-3639.2022.04.010.

摘要

中国抗癌协会乳腺癌专业委员会于2020年4月—2021年11月

采用改编《欧盟委员会乳腺癌指南》的方法

编写制定了《中国乳腺癌筛查和早期诊断指南》（后文简称指南）。指南遵循GRADE系统方法

共包括50条推荐意见和5条专家共识

涉及乳腺癌的筛查、早期诊断、复发风险基因检测以及筛查项目中的沟通和培训等专业领域。指南推荐意见的形成考虑了目前最佳循证医学证据、中国女性群体的价值观念与偏好、成本和资源配置等因素。在应用本指南推荐的筛查和诊断技术时

应结合各地实际情况。

Abstract

Between April 2020 and November 2021

the Chinese Breast Cancer Society developed practice guideline on screening and early diagnosis of breast cancer in China

which was adapted from European Commission Initiative on Breast Cancer with GRADE approach. This practice guideline includes 50 recommendations and 5 expert consensus statements

with a scope of screening

early diagnosis

genetic testing on recurrence risk

and communication and training in the screening program. The formulation of recommendations considered best available evidence-based medicine

sense of worth and preferences of Chinese women

and cost and resource utilization. The implementation of recommended screening and diagnostic strategies need to consider the local contexts.

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.21660 http://doi.org/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660

FENG R M , ZONG Y N , CAO S M , et al . Current cancer situation in China: good or bad news from the 2018 global cancer statistics? [J ] . Cancer Commun (Lond ), 2019 , 39 ( 1 ): 22 .

WEN D G , WEN X D , YANG Y , et al . Urban rural disparity in female breast cancer incidence rate in China and the increasing trend in parallel with socioeconomic development and urbanization in a rural setting [J ] . Thorac Cancer , 2018 , 9 ( 2 ): 262 - 272 . DOI: 10.1111/1759-7714.12575 http://doi.org/10.1111/1759-7714.12575 https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.12575 https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.12575

郑莹 , 吴春晓 , 张敏璐 . 乳腺癌在中国的流行状况和疾病特征 [J ] . 中国癌症杂志 , 2013 , 23 ( 8 ): 561 - 569 .

ZHENG Y , WU C X , ZHANG M L . The epidemic and characteristics of female breast cancer in China [J ] . China Oncol , 2013 , 23 ( 8 ): 561 - 569 .

JIN J . JAMA patient page. Breast cancer screening: benefits and harms [J ] . JAMA , 2014 , 312 ( 23 ): 2585 . DOI: 10.1001/jama.2014.13195 http://doi.org/10.1001/jama.2014.13195 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.13195 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.13195

Independent UK Panel on Breast Cancer Screening . The benefits and harms of breast cancer screening: an independent review [J ] . Lancet , 2012 , 380 ( 9855 ): 1778 - 1786 . DOI: 10.1016/S0140-6736(12)61611-0 http://doi.org/10.1016/S0140-6736(12)61611-0 https://linkinghub.elsevier.com/retrieve/pii/S0140673612616110 https://linkinghub.elsevier.com/retrieve/pii/S0140673612616110

李卫芹 , 李蓉 , 刘佩芳 , 等 . 中国乳腺癌筛查模式探讨 [J ] . 中华流行病学杂志 , 2016 , 37 ( 7 ): 1039 - 1043 .

LI W Q , LI R , LIU P F , et al . Discussion of breast cancer screening model in China [J ] . Chin J Epidemiol , 2016 , 37 ( 7 ): 1039 - 1043 .

WU Z J , LIU Y , LI X H , et al . Factors associated with breast cancer screening participation among women in mainland China: a systematic review [J ] . BMJ Open , 2019 , 9 ( 8 ): e028705 . DOI: 10.1136/bmjopen-2018-028705 http://doi.org/10.1136/bmjopen-2018-028705 https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2018-028705 https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2018-028705

SCHÜNEMANN H J , LERDA D , QUINN C , et al . Breast cancer screening and diagnosis: a synopsis of the European breast guidelines [J ] . Ann Intern Med , 2020 , 172 ( 1 ): 46 - 56 . DOI: 10.7326/M19-2125 http://doi.org/10.7326/M19-2125 https://annals.org/aim/fullarticle/2756145/breast-cancer-screening-diagnosis-synopsis-european-breast-guidelines https://annals.org/aim/fullarticle/2756145/breast-cancer-screening-diagnosis-synopsis-european-breast-guidelines

GUYATT G H , OXMAN A D , KUNZ R , et al . Going from evidence to recommendations [J ] . BMJ , 2008 , 336 ( 7652 ): 1049 - 1051 . DOI: 10.1136/bmj.39493.646875.AE http://doi.org/10.1136/bmj.39493.646875.AE https://www.bmj.com/lookup/doi/10.1136/bmj.39493.646875.AE https://www.bmj.com/lookup/doi/10.1136/bmj.39493.646875.AE

GUYATT G H , OXMAN A D , VIST G E , et al . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations [J ] . BMJ , 2008 , 336 ( 7650 ): 924 - 926 . DOI: 10.1136/bmj.39489.470347.AD http://doi.org/10.1136/bmj.39489.470347.AD https://www.bmj.com/lookup/doi/10.1136/bmj.39489.470347.AD https://www.bmj.com/lookup/doi/10.1136/bmj.39489.470347.AD

ALONSO-COELLO P , OXMAN A D , MOBERG J , et al . GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines [J ] . Gac Sanit , 2018 , 32 ( 2 ): 167 .e1-167167.e10.

ALONSO-COELLO P , SCHÜNEMANN H J , MOBERG J , et al . GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction [J ] . Gac Sanit , 2018 , 32 ( 2 ): 166 .e1-166166.e10.

SCHÜNEMANN H J , WIERCIOCH W , BROZEK J , et al . GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT [J ] . J Clin Epidemiol , 2017 , 81 : 101 - 110 . DOI: 10.1016/j.jclinepi.2016.09.009 http://doi.org/10.1016/j.jclinepi.2016.09.009 https://linkinghub.elsevier.com/retrieve/pii/S0895435616304826 https://linkinghub.elsevier.com/retrieve/pii/S0895435616304826

AMENDOEIRA I , ANTTILA A , BELLOCQ J , et al . European guidelines for quality assurance in breast cancer screening and diagnosis [J ] . Ann Oncol , 2008 , 19 ( 4 ): 614 - 622 . DOI: 10.1093/annonc/mdm481 http://doi.org/10.1093/annonc/mdm481 https://linkinghub.elsevier.com/retrieve/pii/S0923753419414348 https://linkinghub.elsevier.com/retrieve/pii/S0923753419414348

SHEN S , ZHOU Y , XU Y , et al . A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women [J ] . Br J Cancer , 2015 , 112 ( 6 ): 998 - 1004 . DOI: 10.1038/bjc.2015.33 http://doi.org/10.1038/bjc.2015.33 https://doi.org/10.1038/bjc.2015.33 https://doi.org/10.1038/bjc.2015.33

SCHÜNEMANN H J , SCHÜNEMANN A H , OXMAN A D , et al . Grading quality of evidence and strength of recommendations for diagnostic tests and strategies [J ] . BMJ , 2008 , 336 ( 7653 ): 1106 - 1110 . DOI: 10.1136/bmj.39500.677199.AE http://doi.org/10.1136/bmj.39500.677199.AE https://www.bmj.com/lookup/doi/10.1136/bmj.39500.677199.AE https://www.bmj.com/lookup/doi/10.1136/bmj.39500.677199.AE

毕晓峰 , 朱娟 , 石菊芳 , 等 . 我国城市乳腺癌高危人群对筛查的接受程度及支付意愿分析 [J ] . 中华健康管理学杂志 , 2019 , 13 ( 5 ): 394 - 399 .

BI X F , ZHU J , SHI J F , et al . Acceptance and willingness to pay for breast cancer screening among high-risk populations for breast cancer in urban China [J ] . Chin J Heal Manag , 2019 , 13 ( 5 ): 394 - 399 .

CHUA M S , MOK T S , KWAN W H , et al . Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management [J ] . Breast J , 2005 , 11 ( 1 ): 52 - 56 . DOI: 10.1111/j.1075-122X.2005.21480.x http://doi.org/10.1111/j.1075-122X.2005.21480.x https://onlinelibrary.wiley.com/doi/10.1111/j.1075-122X.2005.21480.x https://onlinelibrary.wiley.com/doi/10.1111/j.1075-122X.2005.21480.x

GAN Y X , LAO C K , CHAN A . Breast cancer screening behavior, attitude, barriers among middle-aged Chinese women in Macao, China [J ] . J Public Health (Oxf ), 2018 , 40 ( 4 ): e560-e570.

WONG F M F , CHENG W L S . Breast cancer screening practice and associated factors in menopausal and postmenopausal women [J ] . J Menopausal Med , 2019 , 25 ( 1 ): 41 - 48 . DOI: 10.6118/jmm.2019.25.1.41 http://doi.org/10.6118/jmm.2019.25.1.41 https://e-jmm.org/DOIx.php?id=10.6118/jmm.2019.25.1.41 https://e-jmm.org/DOIx.php?id=10.6118/jmm.2019.25.1.41

田幼红 , 姚汉芬 . 武汉市20万名35-45岁农村籍妇女乳腺癌和宫颈癌筛查状况及意愿分析 [J ] . 中国妇幼保健 , 2016 , 31 ( 9 ): 1832 - 1834 .

TIAN Y H , YAO H F . Analysis on screening status and desire of cervical cancer and breast cancer among 35-45-year-old rural women in Wuhan City [J ] . Matern Child Heal Care China , 2016 , 31 ( 9 ): 1832 - 1834 .

沈松杰 , 孙强 . 中国女性乳腺癌筛查现状及适宜模式探索 [J ] . 协和医学杂志 , 2018 , 9 ( 4 ): 298 - 302 .

SHEN S J , SUN Q . Current status and suitable mode evaluation of breast carcinoma screening in Chinese women [J ] . Med J Peking Union Med Coll Hosp , 2018 , 9 ( 4 ): 298 - 302 .

周星彤 , 沈松杰 , 孙强 . 中国乳腺癌筛查现状及进展 [J ] . 中国医学前沿杂志(电子版) , 2020 , 12 ( 3 ): 6 - 11 .

ZHOU X T , SHEN S J , SUN Q . Current situation and progress of breast cancer screening in China [J ] . Chin J Front Med Sci Electron Version , 2020 , 12 ( 3 ): 6 - 11 .

浏览量

4585

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

中国抗癌协会乳腺癌诊治指南与规范（2026年版）

中国抗癌协会乳腺癌诊治指南与规范（2024年版）

不同组织模式下乳腺癌筛查结果分析

着丝粒蛋白A驱动的染色体不稳定性与乳腺癌相关性研究的进展及展望：机制、预后及临床靶向治疗应用

中国年轻女性乳腺癌发病、死亡近30年的变迁情况及趋势研究